Harrow Health Inc (IMMY) - Financial and Strategic SWOT Analysis Review

Harrow Health Inc (IMMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Harrow Health Inc (Harrow Health) formerly known as Imprimis Pharmaceuticals Inc, owns a portfolio of healthcare businesses which also includes ImprimisRx, the leading ophthalmology pharmaceutical compounding business in the US and holds large equity positions in Eton Pharmaceuticals and Surface Pharmaceuticals. The company is focused on developing innovative medications for serve unmet needs. The company by utilizing its SSP Technology develops injectable Dropless Therapy formulations and topical LessDrops formulations. MAY-44 for treating dyspareunia and MAY-66 for treating bacterial vaginosis (BV) are its proprietary drug candidates. The company markets its products through distributors and compounding pharmacies. Harrow Health is headquartered in San Diego, California, the US.

Harrow Health Inc Key Recent Developments

Aug 14,2019: Harrow Health announces second quarter 2019 results
Jun 25,2019: Harrow Health adds two senior executives to its Nashville team
Jun 18,2019: Harrow Health to locate headquarters in Nashville, Tennessee
May 30,2019: Novel Drug Solutions and Eye Care Northwest terminates agreement with Harrow Health
May 09,2019: Harrow Health announces first quarter 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Harrow Health Inc - Key Facts
Harrow Health Inc - Key Employees
Harrow Health Inc - Key Employee Biographies
Harrow Health Inc - Major Products and Services
Harrow Health Inc - History
Harrow Health Inc - Company Statement
Harrow Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Harrow Health Inc - Business Description
Harrow Health Inc - Corporate Strategy
Harrow Health Inc - SWOT Analysis
SWOT Analysis - Overview
Harrow Health Inc - Strengths
Harrow Health Inc - Weaknesses
Harrow Health Inc - Opportunities
Harrow Health Inc - Threats
Harrow Health Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Harrow Health Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Aug 14, 2019: Harrow Health announces second quarter 2019 results
Jun 25, 2019: Harrow Health adds two senior executives to its Nashville team
Jun 18, 2019: Harrow Health to locate headquarters in Nashville, Tennessee
May 30, 2019: Novel Drug Solutions and Eye Care Northwest terminates agreement with Harrow Health
May 09, 2019: Harrow Health announces first quarter 2019 financial results
Apr 30, 2019: ImprimisRx to introduce new formulations at Cataract & Refractive Surgery Annual Meeting
Mar 12, 2019: Harrow Health announces fourth quarter 2018 financial results
Dec 31, 2018: Imprimis Pharmaceuticals completes name change to Harrow Health
Nov 13, 2018: Imprimis Pharmaceuticals announces third quarter 2018 results
Aug 06, 2018: Imprimis Pharmaceuticals announces second quarter 2018 results
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Harrow Health Inc, Key Facts
Harrow Health Inc, Key Employees
Harrow Health Inc, Key Employee Biographies
Harrow Health Inc, Major Products and Services
Harrow Health Inc, History
Harrow Health Inc, Subsidiaries
Harrow Health Inc, Key Competitors
Harrow Health Inc, Ratios based on current share price
Harrow Health Inc, Annual Ratios
Harrow Health Inc, Annual Ratios (Cont...1)
Harrow Health Inc, Interim Ratios
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Harrow Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Harrow Health Inc, Performance Chart (2014 - 2018)
Harrow Health Inc, Ratio Charts
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Harrow Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Harrow Health Inc (IMMY) - Financial and Strategic SWOT Analysis Review

Harrow Health Inc (IMMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Proteus Digital Health Inc - Product Pipeline Analysis, 2019 Update

Proteus Digital Health Inc (Proteus) is a medical equipment company that develops and sells technology solutions for improving clinical outcomes. The company developed novel category of pharmaceuticals through in-house research

USD 750 View Report

Guardant Health Inc (GH) - Product Pipeline Analysis, 2019 Update

Guardant Health Inc (Guardant Health) is a precision oncology company that commercializes novel therapeutics for cancer. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available